Targeting ApoL1: A 12-Year Journey from Genetic Discovery to Phase 2 Trials
Back
14 Apr 2024
09:54
10:12
Ogo
Egbuna
Speaker
United States
Vertex Pharmaceuticals Inc
Add to My Schedule